FDA warning letters decline by 50%

06/8/2008 | Wall Street Journal, The

The number of warning letters the FDA sent to companies dropped from 1,032 in 2001 to 471 in 2007, following a 2002 policy change requiring the agency's chief counsel office to review such documents. FDA Commissioner Andrew von Eschenbach acknowledged the drop but argued that the agency now issues letters for serious transgressions instead of minor ones.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA